A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced.

The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...

The EMA has extended the indications for Darzalex (daratumumab) to the treatment of adults at high risk of developing ...

Switching from diet sodas to water may help women with type 2 diabetes and obesity or overweight lose more weight and improve ...

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...